Loading...
Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides
Nitazoxanide, the first thiazolide, was originally developed for the treatment of Cryptosporidium parvum. More recently, antiviral activity of nitazoxanide against hepatitis B virus (HBV) and hepatitis C virus was recognized in in vitro systems. These basic studies led to phase II clinical trials th...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The WJG Press
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2670405/ https://ncbi.nlm.nih.gov/pubmed/19370775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.1805 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|